KR102101951B1 - 카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 - Google Patents
카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 Download PDFInfo
- Publication number
- KR102101951B1 KR102101951B1 KR1020180096787A KR20180096787A KR102101951B1 KR 102101951 B1 KR102101951 B1 KR 102101951B1 KR 1020180096787 A KR1020180096787 A KR 1020180096787A KR 20180096787 A KR20180096787 A KR 20180096787A KR 102101951 B1 KR102101951 B1 KR 102101951B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- fraction
- lip
- cow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 239000000284 extract Substances 0.000 title claims abstract description 56
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 210000004761 scalp Anatomy 0.000 title claims abstract description 26
- 235000008749 Caltha palustris Nutrition 0.000 title claims description 15
- 235000015924 Primula veris subsp veris Nutrition 0.000 title claims description 15
- 241000333055 Primula veris subsp. veris Species 0.000 title 1
- 208000001840 Dandruff Diseases 0.000 claims abstract description 32
- 244000072254 Primula veris Species 0.000 claims abstract description 22
- 208000003251 Pruritus Diseases 0.000 claims abstract description 14
- 230000007803 itching Effects 0.000 claims abstract description 13
- 235000002343 Primula veris Nutrition 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 210000004209 hair Anatomy 0.000 claims description 18
- 239000002044 hexane fraction Substances 0.000 claims description 15
- 239000000469 ethanolic extract Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000002453 shampoo Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000000344 soap Substances 0.000 claims description 5
- 230000001256 tonic effect Effects 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000555676 Malassezia Species 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 241000555688 Malassezia furfur Species 0.000 description 2
- 235000016311 Primula vulgaris Nutrition 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- -1 blockers Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000008554 Aloysia triphylla Species 0.000 description 1
- 235000013668 Aloysia triphylla Nutrition 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 240000003285 Caltha palustris Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000969780 Eleotris picta Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001136653 Iris virginica Species 0.000 description 1
- 235000002971 Iris x germanica Nutrition 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000009134 Myrica cerifera Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- SQKZZFWTOOPCDQ-UHFFFAOYSA-N dichloromethane;ethyl acetate;hexane Chemical compound ClCCl.CCCCCC.CCOC(C)=O SQKZZFWTOOPCDQ-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229950004864 olamine Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 카우스립 추출물의 농도에 따른 비듬균에 대한 항균력 평가 실험 결과이다.
도 3은 카우스립 분획물의 농도에 따른 비듬균에 대한 항균력 평가 실험 결과이다. (Hex:n-헥산, MC:메틸렌클로라이드, EA:에틸아세테이트, BuOH:n-부탄올, DW:물)
용매 | 건조중량 (g) |
n-헥산 | 7.05 |
메틸렌클로라이드 | 5.1 |
에틸아세테이트 | 4.7 |
n-부탄올 | 40.75 |
물 | 91.05 |
대조군 | 카우스립 추출물 농도 (v/v) | ||||
0.01 % | 10 % | 8 % | 5 % | 3 % | |
clear zone (mm) |
30 | 17 | 15 | 14 | 10 |
clear zone (mm) | ||||||
시료 | n-헥산 | 메틸렌 클로라이드 |
에틸 아세테이트 |
n-부탄올 | 물 | |
카우스립 분획물 농도 (v/v) |
8 % | 30 | 29 | - | - | - |
4 % | 26 | 22 | - | - | - | |
2 % | 25 | 17 | - | - | - | |
1 % | 22 | 15 | - | - | - | |
대조군 | 0.01 % | 29 |
성분 | 실시예 2 (중량%) | 비교예 1 (중량%) |
카우스립 추출물 | 5.0 | - |
카우스립 n-헥산 분획물 | 5.0 | - |
카우스립 메틸렌클로라이드 분획물 | 5.0 | - |
다이소듐이디티에이 | 0.03 | 0.03 |
폴리쿼터늄-10 | 0.1 | 0.1 |
암모늄라우릴설페이트 | 40.5 | 40.5 |
암모늄라우레스설페이트 | 15.5 | 15.5 |
코카미도프로필베타인 | 6.0 | 6.0 |
프로필렌글라이콜 | 2.0 | 2.0 |
소듐크실렌설포네이트 | 2.0 | 2.0 |
글라이콜다이스테아레이트 | 3.0 | 3.0 |
코카마이드이에이 | 1.0 | 1.0 |
라우라마이드이에이 | 1.0 | 1.0 |
살리실산 | 0.13 | 0.13 |
시메티콘 | 3.0 | 3.0 |
방부제 | 적량 | 적량 |
향 | 적량 | 적량 |
정제수 | 잔량 | 잔량 |
계 | 100.0 | 100.0 |
피검자 | 비듬 감소율 (%) | |
A 그룹 | B 그룹 | |
1 | 50.1 | -5.1 |
2 | 63.5 | 1.2 |
3 | 50.9 | 3.4 |
4 | 51.3 | 4.9 |
5 | 68.4 | -0.7 |
6 | 70.1 | 2.7 |
7 | 66.6 | 2.4 |
8 | 58.5 | 3.4 |
9 | 51.9 | 0.1 |
10 | 62.1 | 1.1 |
평균 | 59.34 | 1.34 |
피검자 | 두피 가려움증 개선 정도 | |
A 그룹 | B 그룹 | |
1 | 2 | -1 |
2 | 1 | 0 |
3 | 2 | 0 |
4 | 2 | 0 |
5 | 3 | -1 |
6 | 2 | -1 |
7 | 2 | -2 |
8 | 1 | 0 |
9 | 0 | 1 |
10 | 3 | -3 |
평균 | 1.8 | -0.72 |
성분 | 제조예 1 (중량%) |
카우스립 추출물 | 5.0 |
카우스립 n-헥산 분획물 | 5.0 |
카우스립 메틸렌클로라이드 분획물 | 5.0 |
다이소듐이디티에이 | 0.02 |
하이드록시에틸셀룰로오스 | 0.2 |
판테놀 | 0.05 |
프로필렌글라이콜 | 1.5 |
글리세린 | 2.0 |
세틸알코올 | 3.5 |
스테아릴알코올 | 1.5 |
글리세릴스테아레이트에스이 | 0.5 |
디메치콘 | 1.5 |
방부제 | 적량 |
향 | 적량 |
정제수 | 잔량 |
계 | 100.0 |
성분 | 제조예 2 (중량%) |
카우스립 추출물 | 5.0 |
카우스립 n-헥산 분획물 | 5.0 |
카우스립 메틸렌클로라이드 분획물 | 5.0 |
다이소듐이디티에이 | 0.05 |
판테놀 | 0.1 |
글리세린 | 5.0 |
카보머 | 0.6 |
하이드록시에칠셀룰로오스 | 0.3 |
에탄올 | 7.0 |
폴리옥시에칠렌경화피마자유 | 1.0 |
트리에탄올아민 | 0.6 |
폴리비닐피롤리돈 | 5.0 |
방부제 | 적량 |
향 | 적량 |
정제수 | 잔량 |
계 | 100.0 |
성분 | 제조예 3 (중량%) |
카우스립 추출물 | 5.0 |
카우스립 n-헥산 분획물 | 5.0 |
카우스립 메틸렌클로라이드 분획물 | 5.0 |
다이소듐이디티에이 | 0.02 |
판테놀 | 0.5 |
부틸렌글라이콜 | 10.0 |
에탄올 | 18.0 |
멘톨 | 0.03 |
폴리솔베이트 80 | 1.0 |
이미다졸리디닐우레아 | 0.2 |
바이오틴 | 0.1 |
향 | 적량 |
정제수 | 잔량 |
계 | 100.0 |
성분 | 제조예 4 (중량%) |
카우스립 추출물 | 5.0 |
카우스립 n-헥산 분획물 | 5.0 |
카우스립 메틸렌클로라이드 분획물 | 5.0 |
정제수 | 2.0 |
트리콜린산 | 2.0 |
미네랄오일 | 1.0 |
폴리에틸렌글리콜 | 0.5 |
향 | 0.1 |
트리브롬살란 | 0.1 |
헥사클로로펜 | 0.1 |
에틸렌디아민아세테이트산 | 0.1 |
이산화티탄 | 0.1 |
비누베이스 | 잔량 |
계 | 100.0 |
Claims (7)
- 카우스립(Primula veris) 추출물을 포함하며,
상기 카우스립 추출물은 n-헥산 분획물 또는 메틸렌클로라이드 분획물 중 하나 이상을 함유하는 것을 특징으로 하는 비듬 개선용 화장료 조성물.
- 카우스립(Primula veris) 추출물을 포함하며,
상기 카우스립 추출물은 n-헥산 분획물 또는 메틸렌클로라이드 분획물 중 하나 이상을 함유하는 것을 특징으로 하는 두피 가려움증 개선용 화장료 조성물.
- 삭제
- 에탄올을 용매로 하여 카우스립으로부터 에탄올 추출물을 추출하는 단계;
추출된 에탄올 추출물을 농축시킨 후, 물에 용해시키는 단계;
용해 후, n-헥산으로 분획하여 n-헥산 분획물을 수득하고, 물 층을 분리하는 단계; 및
분리된 물 층을 메틸렌클로라이드로 분획하여 메틸렌클로라이드 분획물을 수득하는 단계;를 거친 후, 상기 n-헥산 분획물 또는 메틸렌클로라이드 분획물 중 하나 이상을 화장료 조성물에 첨가하는 것을 특징으로 하는 비듬 개선용 화장료 조성물의 제조방법.
- 에탄올을 용매로 하여 카우스립으로부터 에탄올 추출물을 추출하는 단계;
추출된 에탄올 추출물을 농축시킨 후, 물에 용해시키는 단계;
용해 후, n-헥산으로 분획하여 n-헥산 분획물을 수득하고, 물 층을 분리하는 단계; 및
분리된 물 층을 메틸렌클로라이드로 분획하여 메틸렌클로라이드 분획물을 수득하는 단계;를 거친 후, 상기 n-헥산 분획물 또는 메틸렌클로라이드 분획물 중 하나 이상을 화장료 조성물에 첨가하는 것을 특징으로 하는 두피 가려움증 개선용 화장료 조성물의 제조방법.
- 제1항 또는 제2항에 있어서,
상기 카우스립 추출물은,
화장료 조성물 전체에 대하여 0.01 내지 80.0 중량% 첨가되는 것을 특징으로 하는 화장료 조성물.
- 제1항 또는 제2항에 있어서,
상기 화장료 조성물은,
샴푸, 린스, 헤어젤, 헤어토닉, 비누 중 선택되는 어느 하나인 것을 특징으로 하는 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180096787A KR102101951B1 (ko) | 2018-08-20 | 2018-08-20 | 카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180096787A KR102101951B1 (ko) | 2018-08-20 | 2018-08-20 | 카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200021258A KR20200021258A (ko) | 2020-02-28 |
KR102101951B1 true KR102101951B1 (ko) | 2020-04-28 |
Family
ID=69638398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180096787A Active KR102101951B1 (ko) | 2018-08-20 | 2018-08-20 | 카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102101951B1 (ko) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100967018B1 (ko) | 2003-04-09 | 2010-06-30 | 애경산업(주) | 식물 추출물을 함유한 피부 미백 화장료 |
JP5970148B2 (ja) | 2008-09-12 | 2016-08-17 | 丸善製薬株式会社 | チロシナーゼ活性阻害剤、メラニン産生抑制剤、及びSCFmRNA発現抑制剤 |
-
2018
- 2018-08-20 KR KR1020180096787A patent/KR102101951B1/ko active Active
Non-Patent Citations (1)
Title |
---|
MERCOLA, 지루성 피부염: 질환 소개, 증상 그리고 치료법,[online], (2018.03.13. 공개)* |
Also Published As
Publication number | Publication date |
---|---|
KR20200021258A (ko) | 2020-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI433680B (zh) | 新化妝品及/或藥學組合物與其應用 | |
KR101503922B1 (ko) | 검은 곡물 추출물을 유효성분으로 포함하는 모발 화장료조성물 | |
KR101662545B1 (ko) | 발모효과 및 탈모방지 효과가 증진된 천연 추출물의 제조방법 및 상기 방법에 의해 제조된 천연 추출물을 함유하는 두발세정제 | |
KR102307509B1 (ko) | 탈모 및 두피 관리용 조성물 | |
JP3407935B2 (ja) | 皮膚外用剤 | |
CN111012693B (zh) | 一种多效头皮护理组合物、制备方法及其应用 | |
KR20090095359A (ko) | 그리포니아 추출물과 편백 추출물을 유효성분으로 포함하는모발용 조성물 | |
EP1967233B1 (en) | Aqueous external preparation for the treatment of scalp | |
KR102175249B1 (ko) | 인삼 추출물과 녹차 추출물을 함유하는 모발 또는 두피 상태 개선용 조성물 | |
JPH05255044A (ja) | 養毛料 | |
KR102101951B1 (ko) | 카우스립 추출물을 포함하는 두피 개선용 화장료 조성물 | |
KR101973638B1 (ko) | 콩잎 추출물을 포함하는 모발 및 두피 상태 개선용 조성물 | |
KR20130092260A (ko) | 항비듬용 두피 조성물 | |
KR101177500B1 (ko) | 육모용 조성물 | |
EP1933807B1 (en) | Cosmetic product for the treatment of scalp | |
KR102052517B1 (ko) | 인삼 다당체와 녹차 다당체를 함유하는 모발 또는 두피 상태 개선용 조성물 | |
JP3542700B2 (ja) | 頭部用組成物 | |
KR101957845B1 (ko) | 콩뿌리 추출물을 포함하는 모발 및 두피 상태 개선용 조성물 | |
JP4577596B2 (ja) | 育毛剤又は発毛剤及びその使用方法 | |
KR20140115228A (ko) | 생약재의 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용 조성물 | |
KR102076002B1 (ko) | 구상나무 추출물을 포함하는 모발과 두피 상태 개선용 조성물 | |
KR101456655B1 (ko) | 비듬 및 두피가려움의 예방 및 치료용 조성물 | |
KR102063504B1 (ko) | 가공한 인삼 및 녹차에서 추출한 다당체를 함유하는 모발 또는 두피 상태 개선용 조성물 | |
KR20190074618A (ko) | 한약재 발효액을 함유하는 탈모방지용 천연 샴푸 조성물 및 이의 제조방법 | |
KR0154210B1 (ko) | 두발 화장품 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20180820 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20191023 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200325 |
|
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200410 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200410 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240409 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20250408 Start annual number: 6 End annual number: 6 |